Gilles Bouchard

Gilles Bouchard serves as the Chairman of the Board for the Charcot-Marie-Tooth Association since March 2016, focusing on supporting drug development and improving quality of life for individuals with CMT. As the Founder of Bouchard & Associates since 2016, Gilles has also held prominent leadership roles such as Chairman and CEO at Livescribe Inc. (2011-2015) and President and CEO at Opnext (2007-2010). Prior to these positions, extensive experience was gained during a significant tenure at HP from 1989 to 2007, where roles included EVP of Global Operations and CIO. Additionally, experience began at IBM Watson Research Center as a Member of Research Staff (1984-1988). Educational credentials include Executive Education from Harvard Business School and INSEAD, a Master of Science in Engineering from the University of California, Berkeley, and a Diplôme d'Ingénieur from Centrale Lyon.